ATE416381T1 - Verfahren für den nachweis von prionproteinen - Google Patents

Verfahren für den nachweis von prionproteinen

Info

Publication number
ATE416381T1
ATE416381T1 AT03708361T AT03708361T ATE416381T1 AT E416381 T1 ATE416381 T1 AT E416381T1 AT 03708361 T AT03708361 T AT 03708361T AT 03708361 T AT03708361 T AT 03708361T AT E416381 T1 ATE416381 T1 AT E416381T1
Authority
AT
Austria
Prior art keywords
prion
cells
sample
prion proteins
prions
Prior art date
Application number
AT03708361T
Other languages
English (en)
Inventor
Masato Enari
Peter Kloehn
Eckhard Flechsig
Lars Stoltze
Charles Weissmann
Original Assignee
D Gen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D Gen Ltd filed Critical D Gen Ltd
Application granted granted Critical
Publication of ATE416381T1 publication Critical patent/ATE416381T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2828Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Semiconductor Lasers (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT03708361T 2002-03-20 2003-03-20 Verfahren für den nachweis von prionproteinen ATE416381T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0206585.2A GB0206585D0 (en) 2002-03-20 2002-03-20 Method

Publications (1)

Publication Number Publication Date
ATE416381T1 true ATE416381T1 (de) 2008-12-15

Family

ID=9933371

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03708361T ATE416381T1 (de) 2002-03-20 2003-03-20 Verfahren für den nachweis von prionproteinen

Country Status (9)

Country Link
US (1) US20050221320A1 (de)
EP (1) EP1485714B1 (de)
JP (1) JP2005520560A (de)
AT (1) ATE416381T1 (de)
AU (1) AU2003212541B2 (de)
CA (1) CA2478220A1 (de)
DE (1) DE60325028D1 (de)
GB (1) GB0206585D0 (de)
WO (1) WO2003081249A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10328125A1 (de) * 2003-06-23 2005-01-13 Roche Diagnostics Gmbh Nachweis von Protease-resistentem Prion-Protein nach spontaner Transformationsreaktion
GB2429018A (en) 2004-04-23 2007-02-14 Laura Manuelidis High throughput assays for transmissible spongiform encephalopathies
GB201015569D0 (en) * 2010-09-16 2010-10-27 Medical Res Council Blood assay for prions

Also Published As

Publication number Publication date
GB0206585D0 (en) 2002-05-01
US20050221320A1 (en) 2005-10-06
EP1485714A2 (de) 2004-12-15
AU2003212541A1 (en) 2003-10-08
WO2003081249A3 (en) 2003-11-06
JP2005520560A (ja) 2005-07-14
CA2478220A1 (en) 2003-10-02
DE60325028D1 (de) 2009-01-15
AU2003212541B2 (en) 2008-06-26
EP1485714B1 (de) 2008-12-03
WO2003081249A2 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
ES2316597T8 (es) Instrumentos analíticos, biosensores y métodos
ATE543098T1 (de) Identifizierung und isolierung somatischer stammzellen und verwendungen davon
ATE528648T1 (de) Verfahren zum nachweis antikörper-herstellender zellen
DK0815257T3 (da) Fremgangsmåde til karakterisering af biologisk aktive stoffer
DE60215339D1 (de) Spezifische detektionsmedien für staphylococcus aureus und identifizierungs- und/oder zaehlmethode unter verwendung besagter detektionsmedien
DK1432786T3 (da) Hurtig detektion af replikerede celler
CY1111098T1 (el) Bodipy διαιθυλοακεταλη αμινοακεταλδεϋδης
ATE417274T1 (de) Verfahren zur identifizierung von mit zap-70 wechselwirkenden molekülen und zur zap-70- reinigung
ATE408829T1 (de) Verfahren und assaykits zum nachweis mononuklearer zellphänotypen
ATE546543T1 (de) Screening-verfahren mit verwendung des neuen substrats epha4 für gamma-sekretase
EA200500355A1 (ru) Способ обнаружения, характеристики и мониторинга углеводородных месторождений
ATE336567T1 (de) Zellkulturmedium
ATE416381T1 (de) Verfahren für den nachweis von prionproteinen
ATE459000T1 (de) Verfahren für den nachweis von gad65 selbstreaktiven t-zellen
ATE348190T1 (de) Verfahren zum nachweis von protein- proteininteraktionen in membranen
FR2875242B1 (fr) Nouveaux substrats enzymatiques derives de phenoxazinone et leur utilisation comme revelateur dans la detection de microorganismes a activite peptidase
DK1567661T3 (da) Fremgangsmåder, biosensorer og sæt til detektion og identificering af svampe
ATE534907T1 (de) Verfahren für den nachweis von l523s-expression in biologischen proben
ATE294958T1 (de) Quantitatives fluoreszenz-bestimmungsverfahren für transportproteinenaktivität
SE0302840D0 (sv) Detection method
DE602004030809D1 (de) Test für neurale koloniebildung
ATE403863T1 (de) Verfahren zum nachweis von intrazellulären atp und/oder genexpression
DE60321487D1 (de) Verfahren zur identifizierung und quantifizierung von proteinen, isoformen des angiotensin i umsetzenden enzyms

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties